Characterization of apoptosis signal transduction pathways in HL-5 cardiomyocytes exposed to ischemia/reperfusion oxidative stress model

被引:54
作者
Cicconi, S
Ventura, N
Pastore, D
Bonini, P
Di Nardo, P
Lauro, R
Marlier, LNJL
机构
[1] CNR, CNR, INeMM, I-00173 Rome, Italy
[2] Dept Internal Med, Mol Med Lab, Rome, Italy
[3] Dept Expt Med & Biochem Sci, Lab Signal Transduct, Rome, Italy
[4] Univ Roma Tor Vergata, Dept Internal Med, Lab Cellular & Mol Cardiol, Rome, Italy
关键词
D O I
10.1002/jcp.10219
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
During ischemia/reperfusion (I/R), cardiomyocytes are exposed to sudden lack of nutrients and successively to radical oxygen species (ROS). In the present study, we used the HL-5 cardiac atrial myocyte cell line exposed to serum/glucose depletion added or not in H2O2 to mimic ROS during ischemia, then replaced in their standard culture medium to simulate reperfusion. We investigated the effects of serum/glucose depletion combined or not to ROS exposure on AKT and MAP kinases activation to address the role of each event with respect to apoptosis. We demonstrate that serum/glucose depletion per se did not induce apoptosis when compared to ROS exposure. In particular, ROS recruited p38MAPK and JNK pathways. SB202190 preventing p38MAPK activity, partially protected HL-5 from apoptosis while blocking JNK, thanks to jNKI, further enhanced apoptosis. Blocking phosphatidylinositol (Pl) 3-kinase with LY294002 or ERKs with U0126 was without consequence on apoptosis. Finally, BCL-2 and BCL-X-L/S expression levels were analyzed in cells exposed to 1 h ischemia followed by 12-h reperfusion in the presence or not of SB202190; BCL-2, but not BCL-X-L/S, expression was decreased in ROS treated cells but SB202190 failed to restore BCL-2 level. Our data suggest that p38MAPK activation primarily mediates ROS-induced apoptosis while concomitant JNK activation would represent a scavenger pathway for cells trying to escape apoptosis. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 64 条
  • [1] Life-or-death decisions by the Bcl-2 protein family
    Adams, JM
    Cory, S
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (01) : 61 - 66
  • [2] Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2
    Adderley, SR
    Fitzgerald, DJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) : 5038 - 5046
  • [3] Oxidative stress activates extracellular signal-regulated kinases through Src and ras in cultured cardiac myocytes of neonatal rats
    Aikawa, R
    Komuro, I
    Yamazaki, T
    Zou, YZ
    Kudoh, S
    Tanaka, M
    Shiojima, I
    Hiroi, Y
    Yazaki, Y
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (07) : 1813 - 1821
  • [4] Aikawa R, 2000, CIRCULATION, V102, P2873
  • [5] Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis
    Andreka, P
    Zang, J
    Dougherty, C
    Slepak, TI
    Webster, KA
    Bishopric, NH
    [J]. CIRCULATION RESEARCH, 2001, 88 (03) : 305 - 312
  • [6] The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes
    Bialik, S
    Cryns, VL
    Drincic, A
    Miyata, S
    Wollowick, AL
    Srinivasan, A
    Kitsis, RN
    [J]. CIRCULATION RESEARCH, 1999, 85 (05) : 403 - 414
  • [7] Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7
  • [8] Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion
    Bogoyevitch, MA
    GillespieBrown, J
    Ketterman, AJ
    Fuller, SJ
    BenLevy, R
    Ashworth, A
    Marshall, CJ
    Sugden, PH
    [J]. CIRCULATION RESEARCH, 1996, 79 (02) : 162 - 173
  • [9] Molecular and cellular mechanisms of myocardial stunning
    Bolli, R
    Marbán, E
    [J]. PHYSIOLOGICAL REVIEWS, 1999, 79 (02) : 609 - 634
  • [10] Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death
    Bonny, C
    Oberson, A
    Negri, S
    Sauser, C
    Schorderet, DF
    [J]. DIABETES, 2001, 50 (01) : 77 - 82